|
G |
Kdr |
kinase insert domain receptor |
|
IDA |
|
RGD |
PMID:17360578 |
RGD:2292006 |
NCBI chr14:32,572,031...32,615,204
|
|
G |
Plcb1 |
phospholipase C beta 1 |
|
IDA |
|
RGD |
PMID:15536495 |
RGD:1582557 |
NCBI chr 3:122,059,988...122,772,896
|
|
|
G |
Htr1b |
5-hydroxytryptamine receptor 1B |
|
IDA |
|
RGD |
PMID:12040062 |
RGD:625756 |
NCBI chr 8:91,395,405...91,414,815
|
|
|
G |
Fmr1 |
fragile X messenger ribonucleoprotein 1 |
|
IMP |
|
RGD |
PMID:36536454 |
RGD:401976434 |
NCBI chr X:147,240,239...147,278,057
|
|
G |
Fmr1em1Sage |
FMRP translational regulator 1; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs |
|
IMP |
|
RGD |
PMID:36536454 |
RGD:401976434 |
|
|
G |
Nrxn1 |
neurexin 1 |
|
IMP |
|
RGD |
PMID:25420124 |
RGD:12914797 |
NCBI chr 6:3,177,788...4,323,848
|
|
G |
Nrxn1em1 |
neurexin 1; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs |
|
IMP |
|
RGD |
PMID:25420124 |
RGD:12914797 |
|
|
|
G |
Gad1 |
glutamate decarboxylase 1 |
|
IMP |
|
RGD |
PMID:33293518 |
RGD:158012686 |
NCBI chr 3:75,777,260...75,818,099
|
|
G |
Gad1em15Yyan |
glutamate decarboxylase 1; CRISPR/Cas9 induced mutant 15, Yyan |
|
IMP |
|
RGD |
PMID:33293518 |
RGD:158012686 |
|
|
|
G |
Drd1 |
dopamine receptor D1 |
|
IMP |
compared to wild type |
RGD |
PMID:27483345 |
RGD:13825241 |
NCBI chr17:10,545,488...10,550,029
|
|
G |
Drd1m1Hubr |
dopamine receptor D1; ENU induced mutant 1, Hubr |
|
IMP |
compared to wild type |
RGD |
PMID:27483345 |
RGD:13825241 |
|
|
G |
Fmr1 |
fragile X messenger ribonucleoprotein 1 |
|
IMP |
|
RGD |
PMID:24773431 PMID:28894415 |
RGD:9831152, RGD:38501107 |
NCBI chr X:147,240,239...147,278,057
|
|
G |
Fmr1em1Mzhe |
FMRP translational regulator 1; CRISPR/Cas9 induced mutant1, Mzhe |
|
IMP |
|
RGD |
PMID:28894415 |
RGD:38501107 |
|
|
G |
Mecp2 |
methyl CpG binding protein 2 |
|
IMP |
|
RGD |
PMID:27313794 |
RGD:11568037 |
NCBI chr X:156,932,481...156,995,981
|
|
G |
Mecp2em1Sage |
methyl CpG binding protein 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs |
|
IMP |
|
RGD |
PMID:27313794 |
RGD:11568037 |
|
|
|
G |
Slc6a4 |
solute carrier family 6 member 4 |
|
IMP |
compared to wild type littermate |
RGD |
PMID:18295409 |
RGD:4889509 |
NCBI chr10:62,322,688...62,357,060
|
|
G |
Slc6a4m1Hubr |
solute carrier family 6 member 4; ZFN induced mutant1, Hubr |
|
IMP |
compared to wild type littermate |
RGD |
PMID:18295409 |
RGD:4889509 |
|
|
|
G |
Gad1 |
glutamate decarboxylase 1 |
|
IMP |
|
RGD |
PMID:33293518 |
RGD:158012686 |
NCBI chr 3:75,777,260...75,818,099
|
|
G |
Gad1em15Yyan |
glutamate decarboxylase 1; CRISPR/Cas9 induced mutant 15, Yyan |
|
IMP |
|
RGD |
PMID:33293518 |
RGD:158012686 |
|
|
|
G |
Dpp4 |
dipeptidylpeptidase 4 |
|
IAGP |
compared to DA/Ztm |
RGD |
PMID:19327106 |
RGD:41408336 |
NCBI chr 3:67,370,794...67,452,422
|
|
G |
Dpp4DPPIV |
dipeptidylpeptidase 4; DPPIV mutant |
|
IAGP |
compared to DA/Ztm |
RGD |
PMID:19327106 |
RGD:41408336 |
|
|
G |
Nlgn3 |
neuroligin 3 |
|
IMP |
|
RGD |
PMID:24773431 |
RGD:9831152 |
NCBI chr X:66,427,926...66,457,378
|
|
G |
Nlgn3em1Sage |
neuroligin 3; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs |
|
IMP |
|
RGD |
PMID:24773431 |
RGD:9831152 |
|
|
|
G |
Rnaset2 |
ribonuclease T2 |
|
IMP |
|
RGD |
PMID:29752287 |
RGD:13781889 |
NCBI chr 1:52,576,344...52,603,151
|
|
G |
Rnaset2em1Sage |
ribonuclease T2; CRISPR/Cas9 induced mutant 1, Sage |
|
IMP |
|
RGD |
PMID:29752287 |
RGD:13781889 |
|
|
G |
Ube3a |
ubiquitin protein ligase E3A |
|
IMP |
|
RGD |
PMID:32066685 |
RGD:126790466 |
NCBI chr 1:119,204,244...119,297,097
|
|
G |
Ube3aem1Jue |
ubiquitin protein ligase E3A; CRISPR/Cas9 induced mutant1, Jue |
|
IMP |
|
RGD |
PMID:32066685 |
RGD:126790466 |
|
|
|
G |
Drd2 |
dopamine receptor D2 |
|
IDA |
decreased after administration of D2 antagonist |
RGD |
PMID:11311883 |
RGD:1581463 |
NCBI chr 8:58,605,403...58,669,339
|
|
G |
Pax6 |
paired box 6 |
|
IAGP |
DNA:frameshift mutation:cds: |
RGD |
PMID:21203536 |
RGD:8552339 |
NCBI chr 3:92,128,772...92,157,022
|
|
G |
Pax6Sey2 |
paired box gene 6, small eye mutation 2 |
|
IAGP |
compared to SD |
RGD |
PMID:21203536 |
RGD:8552339 |
|
|
|
G |
Crebbp |
CREB binding protein |
|
IMP |
|
RGD |
PMID:32206715 |
RGD:126848802 |
NCBI chr10:11,842,307...11,968,266
|
|
G |
Prkar1b |
protein kinase cAMP-dependent type I regulatory subunit beta |
|
IMP |
|
RGD |
PMID:33479380 |
RGD:150519900 |
NCBI chr12:15,492,233...15,624,942
|
|
G |
Prkar1bem2Tua |
protein kinase cAMP-dependent type I regulatory subunit beta; CRISPR/Cas9 induced mutant 2, Tua |
|
IMP |
|
RGD |
PMID:33479380 |
RGD:150519900 |
|
|
G |
Rin1 |
Ras and Rab interactor 1 |
|
IMP |
|
RGD |
PMID:32174475 |
RGD:126790555 |
NCBI chr 1:202,355,729...202,362,731
|
|
G |
Rin1em1Hcz |
Ras and Rab interactor 1; TALEN induced mutant 1, Hcz |
|
IMP |
|
RGD |
PMID:32174475 |
RGD:126790555 |
|
|
|
G |
Dpp4 |
dipeptidylpeptidase 4 |
|
IAGP |
compared to DA/Ztm |
RGD |
PMID:19327106 |
RGD:41408336 |
NCBI chr 3:67,370,794...67,452,422
|
|
G |
Dpp4DPPIV |
dipeptidylpeptidase 4; DPPIV mutant |
|
IAGP |
compared to DA/Ztm |
RGD |
PMID:19327106 |
RGD:41408336 |
|
|
|
G |
Fmr1 |
fragile X messenger ribonucleoprotein 1 |
onset |
IMP |
in juveniles, compared to wild type controls |
RGD |
PMID:36581671 |
RGD:401976427 |
NCBI chr X:147,240,239...147,278,057
|
|
G |
Fmr1em1Sage |
FMRP translational regulator 1; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs |
onset |
IMP |
in juveniles, compared to wild type controls |
RGD |
PMID:36581671 |
RGD:401976427 |
|
|
G |
Shank2 |
SH3 and multiple ankyrin repeat domains 2 |
|
IMP |
|
RGD |
PMID:29970986 |
RGD:126790534 |
NCBI chr 1:208,575,144...209,020,300
|
|
G |
Shank2em13Sage |
SH3 and multiple ankyrin repeat domains 2; ZFN induced mutant13, Sage |
|
IMP |
|
RGD |
PMID:29970986 |
RGD:126790534 |
|
|
|
G |
Bdnf |
brain-derived neurotrophic factor |
|
IAGP |
|
RGD |
PMID:16899727 |
RGD:1600586 |
NCBI chr 3:116,619,633...116,670,212
|
|
G |
Cplx1 |
complexin 1 |
|
IMP |
|
RGD |
PMID:31875236 |
RGD:127285808 |
NCBI chr14:1,184,677...1,216,392
|
|
G |
Fgf2 |
fibroblast growth factor 2 |
|
IMP |
compared to control treated bHR strain |
RGD |
PMID:25071177 |
RGD:405866182 |
NCBI chr 2:122,164,454...122,218,796
|
|
G |
Nlgn3 |
neuroligin 3 |
|
IMP |
|
RGD |
PMID:28958035 |
RGD:126790492 |
NCBI chr X:66,427,926...66,457,378
|
|
G |
Nlgn3em1Sage |
neuroligin 3; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs |
|
IMP |
|
RGD |
PMID:28958035 |
RGD:126790492 |
|
|
G |
Oprl1 |
opioid related nociceptin receptor 1 |
|
IMP |
|
RGD |
PMID:21184763 |
RGD:126925219 |
NCBI chr 3:189,209,495...189,225,406
|
|
G |
Oprl1m1Hubr |
opioid related nociceptin receptor 1; ENU induced mutant1, Hubr |
|
IMP |
|
RGD |
PMID:21184763 |
RGD:126925219 |
|
|
G |
Slc6a4 |
solute carrier family 6 member 4 |
|
IMP |
compared to wild type littermate |
RGD |
PMID:18295409 |
RGD:4889509 |
NCBI chr10:62,322,688...62,357,060
|
|
G |
Slc6a4m1Hubr |
solute carrier family 6 member 4; ZFN induced mutant1, Hubr |
|
IMP |
compared to wild type littermate |
RGD |
PMID:18295409 |
RGD:4889509 |
|
|
|
G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
sexual_dimorphism |
IMP |
compared to male wild type littermate |
RGD |
PMID:31329100 |
RGD:407571699 |
NCBI chr18:31,522,783...31,644,508
|
|
G |
Nr3c1em1Kuan |
nuclear receptor subfamily 3, group C, member 1; CRISPR/Cas9 induced mutant1, Kuan |
sexual_dimorphism |
IMP |
compared to male wild type littermate |
RGD |
PMID:31329100 |
RGD:407571699 |
|
|
G |
Oprl1 |
opioid related nociceptin receptor 1 |
|
IMP |
|
RGD |
PMID:21184763 |
RGD:126925219 |
NCBI chr 3:189,209,495...189,225,406
|
|
G |
Oprl1m1Hubr |
opioid related nociceptin receptor 1; ENU induced mutant1, Hubr |
|
IMP |
|
RGD |
PMID:21184763 |
RGD:126925219 |
|
|
|
G |
Cplx1 |
complexin 1 |
|
IMP |
|
RGD |
PMID:31875236 |
RGD:127285808 |
NCBI chr14:1,184,677...1,216,392
|
|
G |
Dpp4 |
dipeptidylpeptidase 4 |
|
IAGP |
compared to DA/Ztm |
RGD |
PMID:19327106 |
RGD:41408336 |
NCBI chr 3:67,370,794...67,452,422
|
|
G |
Dpp4DPPIV |
dipeptidylpeptidase 4; DPPIV mutant |
|
IAGP |
compared to DA/Ztm |
RGD |
PMID:19327106 |
RGD:41408336 |
|
|
|
G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
sexual_dimorphism |
IMP |
compared to female wild type littermate |
RGD |
PMID:31329100 |
RGD:407571699 |
NCBI chr18:31,522,783...31,644,508
|
|
G |
Nr3c1em1Kuan |
nuclear receptor subfamily 3, group C, member 1; CRISPR/Cas9 induced mutant1, Kuan |
sexual_dimorphism |
IMP |
compared to female wild type littermate |
RGD |
PMID:31329100 |
RGD:407571699 |
|
|
|
G |
Slc6a4 |
solute carrier family 6 member 4 |
|
IMP |
|
RGD |
PMID:18581099 |
RGD:4889490 |
NCBI chr10:62,322,688...62,357,060
|
|
G |
Slc6a4m1Hubr |
solute carrier family 6 member 4; ZFN induced mutant1, Hubr |
|
IMP |
|
RGD |
PMID:18581099 |
RGD:4889490 |
|
|
|
G |
Ar |
androgen receptor |
|
IAGP |
|
RGD |
PMID:24269497 |
RGD:10043340 |
NCBI chr X:63,104,771...63,273,934
|
|
G |
Crhr1 |
corticotropin releasing hormone receptor 1 |
|
IDA |
in an induced arthritis pain model |
RGD |
PMID:17550594 |
RGD:1626231 |
NCBI chr10:89,540,192...89,583,466
|
|
|
G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
sexual_dimorphism |
IMP |
associated with abnormal freezing behavior (MP:0020420); compared to female wild type littermate |
RGD |
PMID:31329100 |
RGD:407571699 |
NCBI chr18:31,522,783...31,644,508
|
|
G |
Nr3c1em1Kuan |
nuclear receptor subfamily 3, group C, member 1; CRISPR/Cas9 induced mutant1, Kuan |
sexual_dimorphism |
IMP |
associated with abnormal freezing behavior (MP:0020420); compared to female wild type littermate |
RGD |
PMID:31329100 |
RGD:407571699 |
|
|